Pierre Giglio to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications Pierre Giglio has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.245
-
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73.
Score: 0.117
-
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
Score: 0.079
-
Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma. J Neurooncol. 2022 Jan; 156(2):399-406.
Score: 0.049